All affected individuals were found to be GJB2-negative, allowing us to exclude the predominantly implicated gene in deafness in many populations [20, 21] The CES approach we have then utilized along with the appropriate variant prioritization strategy revealed two candidate variants in the MYO15A and the OTOF genes. The gene discussed is GJB2; the disease is deafness.